FDA Inspection
Tongling Jieya Biologic Technology Stock Co., Ltd.Tongling Jieya Biologic Technology Stock Co., Ltd. – FDA Inspection, Dec 9, 2016
Record Details
This FDA Inspection record concerns Tongling Jieya Biologic Technology Stock Co., Ltd., with an inspection on December 9, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- December 9, 2016
- Product Type
- Drugs
View Company Profile
ID · c2f7d51a-cfd3-4cd3-b72e-97c162d1dac5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 995169
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.160(a)Deviations from laboratory control requirements
- 21 CFR 211.194(a)(4)Complete Test Data
- 21 CFR 211.194(a)(2)Suitability of testing methods verified
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Tongling Jieya Biologic Technology Stock Co., Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 21, 2025 | Not classified | Office of Inspections and Investigations | |
| December 20, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Tongling Jieya Biologic Technology Stock Co., Ltd.
- FDA Inspection 1266873 - 2025-03-21
- FDA Inspection 1080593 - 2018-12-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.